Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Acthar low dose (40 U)1件: Corticotropin1件: Corticotropin 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 49 💬
2Administration of a low dose of desipramine1件: Desipramine1件: Desipramine 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156 💬
3Ambrisentan - low dose1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4AXO-AAV-GM2 Low Dose----1件: 19 💬
5BI 655064 low dose----1件: 46 💬
6BIIL 284 BS low dose----1件: 46 💬
7BIIL 284 BS, low dose----1件: 299 💬
8BIIL 284 BS, low dose, adult patients----1件: 299 💬
9BIIL 284 BS, low dose, pediatric patients----1件: 299 💬
10BIRB 796 BS, low dose----1件: 46 💬
11BLI-1300 low dose----1件: 96 💬
12Brazikumab low dose1件: Brazikumab1件: Brazikumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
13Clobazam Low Dose1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
14CPL500036 - low dose----1件: 6 💬
15CVT-301 Low Dose----1件: 6 💬
16Cyclosporin, low dose steroid1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
17Elamipretide (low dose)1件: Elamipretide1件: Elamipretide 💬 --1件: 21 💬
18Enpatoran low dose----1件: 49 💬
19EUR-1008 (APT-1008) Low Dose----1件: 298 💬
20Fentanyl (Low Dose)1件: Fentanyl1件: Fentanyl 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215 💬
21Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		2件: Fentanyl ,
Dexmedetomidine 💬 		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬 		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
22GTX-102 low dose fast Period 1 and Period 21件: GTX-102---1件: 65 💬
23HMPL-004 low dose----1件: 97 💬
24IgPro20 (low dose)----1件: 14 💬
25Iloprost low dose1件: Iloprost1件: Iloprost 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
26Imsidolimab low dose1件: Imsidolimab1件: Imsidolimab 💬 1件: IL1RL2 💬 1件: Cytokine-cytokine receptor interaction 💬1件: 37 💬
27KPS-0373, Low dose----1件: 18 💬
28KW-6356 Low Dose1件: KW-6356---1件: 6 💬
29Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP5件: Dapsone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone,
Triamcinolone		5件: Triamcinolone ,
Prednisolone ,
Dapsone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬 		3件: IMPDH1,
IMPDH2,
NR3C1 💬 		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 162 💬
30LiRIS low dose and LiRIS high dose----1件: 226 💬
31Low dose----1件: 97 💬
32Low dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
33Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day1件: Vitamin D---1件: 13 💬
34Low Dose Aspirin (162 mg/day)1件: Acetylsalicylic acid (Low Dose Miniprin Enteric Safety Coated)1件: Aspirin 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
35Low dose BIBF 1120 twice daily----1件: 85 💬
36Low dose BIBF1120 once daily----1件: 85 💬
37Low Dose Budesonide1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
38Low dose budesonide tablet1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
39Low dose cannabis1件: Medical Cannabis---1件: 13 💬
40Low dose levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
41Low dose LX2006----1件: 18 💬
42Low Dose Mesenchymal Stem Cells (MSCs)----1件: 49 💬
43Low Dose MT-1303----1件: 97 💬
44Low Dose MYOBLOC1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
45Low dose naltrexone1件: Naltrexone1件: Naltrexone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97 💬
46Low dose of BIIL 284 BS tablets----1件: 46 💬
47Low dose ORTD-1----1件: 46 💬
48Low dose prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
49Low dose TSO----1件: 96 💬
50Low dose vehicle control----1件: 46 💬
51Low Dose-VIS649----1件: 66 💬
52LX3305 low dose----1件: 46 💬
53M5049 low dose----1件: 49 💬
54MEDI7183 low dose----1件: 97 💬
55MMX Mesalamine/Mesalazine (Low Dose)1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
56MT-1303 Low dose----1件: 49 💬
57MT-7117 Low Dose----1件: 254 💬
58MultiStem low dose1件: MultiStem---1件: 97 💬
59Mycophenolate mofetil, low dose steroid2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222 💬
60OCU400 Low Dose----1件: 90 💬
61Orelabrutinib (Low Dose)1件: Orelabrutinib1件: Orelabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49 💬
62PF-06649751 low dose (1 mg QD)1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
63PHA-022121 low dose----1件: 65 💬
64Prednisone, low dose rituximab2件: Prednisone,
Rituximab		2件: Prednisone ,
Rituximab 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61 💬
65PXT3003 Low dose----1件: 10 💬
66Ravicti low dose1件: Glycerol phenylbutyrate1件: Glycerol phenylbutyrate 💬 --1件: 299 💬
67SA001 Low dose----1件: 53 💬
68SC0062 low dose----1件: 66 💬
69SEN0014196 (Low Dose)----1件: 8 💬
70TAS5315 low dose----1件: 46 💬
71Tiotropium bromide-low dose-2.5mcg1件: Tiotropium---1件: 299 💬
72Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)2件: Methylprednisolone,
Ursodeoxycholic acid		2件: Methylprednisolone ,
Ursodiol 💬 		2件: NR1H4,
NR3C1 💬 		2件: Bile secretion, Neuroactive ligand-receptor interaction 💬1件: 93 💬
73YRA-1909 low dose----1件: 46 💬